BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 16215883)

  • 1. Is it worth removing albumin-bound substances in hepatic encephalopathy?
    Blei AT
    Z Gastroenterol; 2001 Jun; 39 Suppl 2():8. PubMed ID: 16215883
    [No Abstract]   [Full Text] [Related]  

  • 2. Albumin-bound substances--a new target in liver failure therapy.
    Mitzner S; Stange J; Klammt S; Peszynski P; Hickstein H; Korten G; Schmidt R
    Z Gastroenterol; 2001 Jun; 39 Suppl 2():6-7. PubMed ID: 16215882
    [No Abstract]   [Full Text] [Related]  

  • 3. Preliminary results of a phase I trial evaluating an extracorporeal hepatic support device utilizing albumin dialysis.
    Awad SS; Swaniker F; Bartlett RH
    Z Gastroenterol; 2001 Jun; 39 Suppl 2():22-3. PubMed ID: 16215890
    [No Abstract]   [Full Text] [Related]  

  • 4. Drugs in liver disease and during albumin dialysis -MARS.
    Majcher-Peszynska J; Peszynski P; Müller SC; Klammt S; Wacke R; Mitzner S; Stange J; Mundkowski R; Hehl EM; Schmidt R; Drewelow B
    Z Gastroenterol; 2001 Jun; 39 Suppl 2():33-5. PubMed ID: 16215894
    [No Abstract]   [Full Text] [Related]  

  • 5. Subclinical hepatic encephalopathy: role of tryptophan binding to albumin and the competition with indole-3-acetic acid.
    Greco AV; Mingrone G; Favuzzi A; Bertuzzi A; Gandolfi A; DeSmet R; Vanholder R; Gasbarrini G
    J Investig Med; 2000 Jul; 48(4):274-80. PubMed ID: 10916286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of split-liver recipients with poor graft function by albumin-dialysis (Mars).
    Loock J; Treichel U; Gerken G; Malago M; Broelsch C; Philipp T; Heemann U
    Z Gastroenterol; 2001 Jun; 39 Suppl 2():18-9. PubMed ID: 16215888
    [No Abstract]   [Full Text] [Related]  

  • 7. First experience in Spain with MARS in three patients with advanced liver failure.
    Aviles J; Macia M; Perez F; Moreno A; Navarro JF; Morales S; Medina ML; Aguiar R; Garcia J
    Z Gastroenterol; 2001 Jun; 39 Suppl 2():20-1. PubMed ID: 16215889
    [No Abstract]   [Full Text] [Related]  

  • 8. Binding of tryptophan to albumin in liver cirrhosis: a reappraisal of the problem.
    Zoli M; Marchesini G; Cecchini L; Dondi C; Bianchi FB; Pisi E
    Hepatogastroenterology; 1981 Apr; 28(2):87-9. PubMed ID: 7216152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificial liver support as a bridge to orthotopic liver transplantation in a case of acute liver dysfunction on non-alcoholic steatohepatitis (NASH).
    Gaspari R; Pennisi MA; Mignani V; Gasbarrini A; Mercurio G; Di Campli C; Conti G; Gentiloni Silveri N; Proietti R
    Z Gastroenterol; 2001 Jun; 39 Suppl 2():15-7. PubMed ID: 16215887
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful clinical application of extracorporal albumin dialysis in a patient with benign recurrent intrahepatic cholestasis (BRIC).
    Huster D; Schubert C; Achenbach H; Caca K; Mössner J; Berr F
    Z Gastroenterol; 2001 Jun; 39 Suppl 2():13-4. PubMed ID: 16215886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hepatix extracorporeal liver assist device in the treatment of fulminant hepatic failure.
    Kelly JH; Sussman NL
    ASAIO J; 1994; 40(1):83-5. PubMed ID: 7514459
    [No Abstract]   [Full Text] [Related]  

  • 12. Tryptophan and hepatic coma.
    Ono J; Hutson DG; Dombro RS; Levi JU; Livingstone A; Zeppa R
    Gastroenterology; 1978 Feb; 74(2 Pt 1):196-200. PubMed ID: 620892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of a phase I trial evaluating a liver support device utilizing albumin dialysis.
    Awad SS; Swaniker F; Magee J; Punch J; Bartlett RH
    Surgery; 2001 Aug; 130(2):354-62. PubMed ID: 11490371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tryptophan and hepatic coma.
    Rakes GE
    Gastroenterology; 1979 Mar; 76(3):655-6. PubMed ID: 107058
    [No Abstract]   [Full Text] [Related]  

  • 15. [Extracorporeal perfusion with baboon livers for the management of hepatic coma].
    Fischer M; Vogel GE; Bottermann P
    Dtsch Med Wochenschr; 1977 Dec; 102(50):1862. PubMed ID: 590119
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of acute hepatic encephalopathy.
    Chamuleau RA
    Neth J Med; 1979; 22(6):203-9. PubMed ID: 118390
    [No Abstract]   [Full Text] [Related]  

  • 17. GABA, benzodiazepines and hepatic encephalopathy.
    Wilkinson SP
    Eur J Gastroenterol Hepatol; 1995 Apr; 7(4):323-4. PubMed ID: 7600137
    [No Abstract]   [Full Text] [Related]  

  • 18. A new procedure for the removal of protein bound drugs and toxins.
    Stange J; Mitzner S; Ramlow W; Gliesche T; Hickstein H; Schmidt R
    ASAIO J; 1993; 39(3):M621-5. PubMed ID: 8268613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Albumin regeneration in liver support-comparison of different methods.
    Mitzner S; Klammt S; Stange J; Schmidt R
    Ther Apher Dial; 2006 Apr; 10(2):108-17. PubMed ID: 16684211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lone tryptophan residue of human serum albumin as part of the specific warfarin binding site. Binding of dicoumarol to the warfarin, indole and benzodiazepine binding sites.
    Fehske KJ; Müller WE; Wollert U; Velden LM
    Mol Pharmacol; 1979 Nov; 16(3):778-89. PubMed ID: 93690
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.